Immunoglobulins: Global Market Outlook

Report Code: BIO241A

Publish Date: Apr 2023

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The goal is to furnish an up-to-date analysis of the global immunoglobulins market and future opportunities in the market. The report provides an overview of the global immunoglobulins market and examines market trends. It also highlights major trends and challenges that affect the market and the vendor landscape. The scope of the study encompasses the current and forecast markets for normal and hyper immunoglobulins , includes market drivers and restraints, the competitive landscape, and current and emerging technologies. It also analyzes key companies and their recent developments, such as product launches, business expansions and collaborations.

Report Includes

  • A brief general outlook of the global market for immunoglobulins
  • Analyses of the global market trends, with historic market revenue data (sales figures) for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Estimation of the actual market size and revenue forecast for the global immunoglobulins market in USD million terms, and corresponding market share analysis by product type, route of administration, and region
  • In-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, current and future prospects in therapeutic treatments, and contributions to the overall market
  • Identification of major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, segmental revenues, and operational integration
  • Company profiles of the market leading players

Report Scope

The scope of this study encompasses the current and forecast markets for normal and hyper immunoglobulins. The report segments markets based on product type and route of administration. The report surveys the competitive landscape, market dynamics and current and developing technologies. The report also analyzes the impact of COVID-19 on the market.

In terms of geographical regions, the report analyzes the market across North America, Europe, Asia-Pacific and the rest of the world (RoW). Key regions such as the U.S., Canada, Europe (U.K., Italy, France and Germany), Asia-Pacific (China, India and Japan) are highlighted in the discussion.

The report also analyzes key companies and their recent developments, such as product launches, business expansions and collaborations.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022 to 2027
Base year market size $18.5 billion
Market size forecast $26.3 billion
Growth rate CAGR of 6.2% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered Type, route of administration, and region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (ROW)
Countries covered U.S., Canada, Germany, France, Italy, U.K., Others, Japan, China, India, Australia, Others
Key Market Drivers
  • Increasing Demand for Immunoglobulins in Therapeutic Treatments
  • Increase in Blood Donations
  • Increasing Research on Alternative Therapies
  • High Manufacturing and Treatment Costs Associated with IG Products
  • Stringent Government Regulations and Low Reimbursement Policies
Companies studied
ADMA BIOLOGICS INC.BAXTER
BIO PRODUCTS LABORATORY LTD.TAIBANG BIOLOGICAL GROUP CO.
CSLGRIFOLS S.A.
INNOVATIVE RESEARCHINTAS PHARMACEUTICALS LTD.
KEDRION S.p.A.LFB S.A.
OCTAPHARMA AGSANQUIN
TAKEDA PHARMACEUTICAL CO. LTD.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The immunoglobulins market is projected to grow from $18.5 billion in 2021 to $26.3 billion in 2027, at a compound annual growth rate (CAGR) of 6.2% during the forecast period.
Increasing demand for immunoglobulins in various therapeutic treatments and increase in blood donations are some of the key factors driving the growth of the immunoglobulins market.
The immunoglobulins market is segmented on the type, route of administration, and region.
Normal Immunoglobulins segment will dominate the market by the end of 2027.
North America has the highest market share.
Grifols, Takeda, CSL, Kedrion, Octapharma, and LFB SA

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Immunoglobulins: Global Market Outlook64Free

Related Reports

Antibody Drugs: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO016M

The global market for antibody drugs is expected to grow from $242.6 billion in 2024 and is projected to reach $412.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.

Global Markets for Blood Plasma Products

Published - Mar 2023 | Publisher - BCC Publishing | Code - HLC201C

The global blood plasma products market should reach $45.7 billion by 2027 from $33.2 billion in 2022 at a compound annual growth rate (CAGR) of 6.6% for the forecast period of 2022 to 2027.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Sep 2021 | Publisher - BCC Publishing | Code - BIO021F

The global protein drugs market should reach $394.2 billion by 2026 from $265.0 billion in 2021 at a compound annual growth rate (CAGR) of 8.3% for the forecast period of 2021 to 2026.

Plasma Fractionation: Global Markets

Published - Dec 2020 | Publisher - BCC Publishing | Code - MDS032A

The global market for plasma fractionation should grow from $28.6 billion in 2020 to $40.4 billion by 2025, at compound annual growth rate (CAGR) of 7.2% for the period of 2020-2025.

Recent Reports

Bioprocess Optimization and Digital Bio-manufacturing: Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - BIO170B

The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.

Global DNA Sequencing: Research, Applied and Clinical Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - BIO045J

The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.

Artificial Intelligence (AI) in Cancer

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO196B

The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Immunoglobulins: Global Market Outlook
Sample Report